#. "You keep insisting on comparing apples and oranges. You are wallowing in the wrong paradigm." WRONG. Comparing a trial in fsg with a trial in a different kidney disease type would be apples and oranges. Comparing a fsg trial with another fsg trial which both use the same endpoints and recruit from same patient group is apples and apples. Pretending the sparsantan phase 3 fgs trial and their discussion with fda don't exist and have no relevance to dimx is unbelievably naive and just dumb.
#. "What is different about your position is the hubris in believing that the trial will be a failure before the event". WRONG AGAIN. Never have I said dimx trial will fail. what I have said is that I think "accelated approval" based on your 144/35wk urine protein results is unlikely and like fda told trevere, dimx will have to do same and complete the full study and come back with 2 year GFR results before approval. that looks to be possibly 4-5 years away. and that scenario looks more likely I'd say now - trevere showed great urine protein urine interim results at week 35 yet flunked their final GFR endpoint result.
and @ owl v fox- throw all the insults you want, usually a sign that they have nothing useful to say and knows that the person they insult is probably on to something..
- Forums
- ASX - By Stock
- DXB
- Ann: ACTION3 IND Approved in China
Ann: ACTION3 IND Approved in China, page-164
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
45.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $250.5M |
Open | High | Low | Value | Volume |
46.5¢ | 47.5¢ | 45.5¢ | $934.4K | 2.015M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 548864 | 45.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.0¢ | 35747 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 453731 | 0.450 |
1 | 68489 | 0.445 |
2 | 20570 | 0.440 |
2 | 27023 | 0.435 |
4 | 50806 | 0.430 |
Price($) | Vol. | No. |
---|---|---|
0.460 | 17769 | 1 |
0.465 | 71700 | 2 |
0.470 | 55000 | 1 |
0.480 | 91130 | 3 |
0.485 | 85000 | 2 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |